| Detected | Trial | Change |
|---|---|---|
| 2026-08-09 | NCT06464614 Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in… |
overall status: Not Yet Recruiting → Unknown |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06418945 | Clinical Study on the Effect of Removal of Porphyromonas Gingivalis on Prognosis of… | Evaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis | Not Yet Recruiting |
| Phase 2 | |||
| NCT07622797 | Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as… | Late-stage Resectable Esophageal Squamous Carcinoma | Recruiting |
| NCT07533305 | Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line… | QL1706 | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT07347080 | A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid… | T2DM | Recruiting |
| Not specified | |||
| NCT02972372 | Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer | Esophagus Cancer | Recruiting |
| NCT06722300 | Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the… | Esophageal Cancer | Active, Not Recruiting |
| NCT07642401 | Large-scale Models of Esophageal Cancer and Related Research | Esophageal Cancer | Enrolling by Invitation |